Sphere Fluidics

Sphere Fluidics

Sphere Fluidics is a company commercializing single cell analysis systems.

All edits

Edits 2 days ago
Golden AI"Wikidata import from WikidataImport1"
Golden AI edited 2 days ago
Edits made to:
Infobox (+1 properties)

Infobox

Wikidata entity ID
Q48803786
Edits on 26 March, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 26 March, 2020 5:36 pm
Edits made to:
Infobox (+1 properties)

Infobox

Total funding amount (USD)
2,474,615
Edits on 17 September, 2019
Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 17 September, 2019 6:37 am
Edits made to:
Article (+5/-5 characters)

Article

On January 29, 2019 Sphere Fluidics completed a venture capital round with $2 million in funding from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund, and 24Haymarket. the company claims it will be using the funding to accelerate the growth of business operations and sales of the companies Cyto-Mine Single Cell Analysis System. The CEO of Sphere Fluidics, FrankFrank F Craig, made the following public statement after the company secures its funding:

Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 17 September, 2019 6:22 am
Edits made to:
Article (+3/-3 characters)

Article

We are pleased to see such a high level of interest in Sphere Fluidics and receive funding from several leading investors. We are making further investment in automating and streamlining our manufacturing processes across our product range to extend our offering and to deliver our high-quality standards and service to more researchers working in biotherapeutic discovery and cell line development across the UK and USAUSA. We will be raising additional funds to expand these capabilities further.
Dawson Sewell
Dawson Sewell edited on 16 September, 2019 1:41 pm
Edits made to:
Article (+1574/-573 characters)

Article

Products

Sphere Fluidics' main products are Cyto-Mine and ESI-Mine.

Cyto-Mine

Cyto-Mine was introduced in September 2018. It is an automated platform which integrates single cell screening, sorting, isolation, and clone verification. The product is meant to work alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line development workflows.

EIS-Mine

ESI-Mine is a platform that can be used for high-throughput mass spectometry (MS) analysis. It enables the retrieval of living copies of hits that are normally destroyed during MS procedures.

Funding

Venture

On January 29, 2019 Sphere Fluidics completed a venture capital round with $2 million in funding from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund, and 24Haymarket. the company claims it will be using the funding to accelerate the growth of business operations and sales of the companies Cyto-Mine Single Cell Analysis System. The CEO of Sphere Fluidics, Frank F Craig, made the following public statement after the company secures its funding:

We are pleased to see such a high level of interest in Sphere Fluidics and receive funding from several leading investors. We are making further investment in automating and streamlining our manufacturing processes across our product range to extend our offering and to deliver our high-quality standards and service to more researchers working in biotherapeutic discovery and cell line development across the UK and USA. We will be raising additional funds to expand these capabilities further.
...

Sphere Fluidics' main products are Cyto-Mine and ESI-Mine. Cyto-Mine was introduced in September 2018. It is an automated platform which integrates single cell screening, sorting, isolation, and clone verification. The product is meant to work alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line development workflows. ESI-Mine is a platform that can be used for high-throughput mass spectometry (MS) analysis. It enables the retrieval of living copies of hits that are normally destroyed during MS procedures.

Edits on 12 June, 2019
Golden AI
Golden AI edited on 12 June, 2019 10:24 pm
Edits made to:
Infobox (+1 properties)
Edits on 20 February, 2019
Melanie Manipula
Melanie Manipula approved a suggestion from Golden's AI on 20 February, 2019 9:36 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 6 February, 2019
Baye Maniago
Baye Maniago approved a suggestion from Golden's AI on 6 February, 2019 9:13 pm
Edits made to:
Infobox (+3 properties)
People (+4 rows) (+8 cells) (+84 characters)

People

Name
Role
Related Golden topics

Andrew Mackintosh

Employee

Paul Mears

Investor

Robert Walsh

Investor

Serena Davoli

Employee

Infobox

Edits on 22 January, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 22 January, 2019 9:29 pm
Edits made to:
Article (+21/-21 characters)

Article

Sphere Fluidics' main products are Cyto-Mine and ESI-Mine. Cyto-Mine was introduced in September 2018. It is an automated platform which integrates single cell screening, sorting, isolation, and clone verification. The product is meant to work alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line developmentcell line development workflows. ESI-Mine is a platform that can be used for high-throughput mass spectometry (MS) analysis. It enables the retrieval of living copies of hits that are normally destroyed during MS procedures.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 22 January, 2019 7:35 pm
Edits made to:
Article (+22/-22 characters)

Article

Sphere Fluidics is a privately held companyprivately held company based in Babraham, Cambridge, UK that commercializes single cell analysis systems. The company was originally spun out from the University of Cambridge and has 32 patented products including, instruments, software, biochips, and specialist chemicals.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 22 January, 2019 7:35 pm
Edits made to:
Article (+8/-8 characters)

Article

Sphere Fluidics is a privately held company based in BabrahamBabraham, Cambridge, UK that commercializes single cell analysis systems. The company was originally spun out from the University of Cambridge and has 32 patented products including, instruments, software, biochips, and specialist chemicals.

Sameeha Sulaiman
Sameeha Sulaiman edited on 22 January, 2019 11:59 am
Edits made to:
Description (+52 characters)
Topic thumbnail

Sphere Fluidics

Company commercializing single cell analysis systems

Sameeha Sulaiman
Sameeha Sulaiman edited on 22 January, 2019 11:58 am
Edits made to:
Infobox (+3 properties)
Article (+867 characters)
People (+7 rows) (+14 cells) (+263 characters)
Related Topics (+1 topics)

Article

Sphere Fluidics is a privately held company based in Babraham, Cambridge, UK that commercializes single cell analysis systems. The company was originally spun out from the University of Cambridge and has 32 patented products including, instruments, software, biochips, and specialist chemicals.

...

Sphere Fluidics' main products are Cyto-Mine and ESI-Mine. Cyto-Mine was introduced in September 2018. It is an automated platform which integrates single cell screening, sorting, isolation, and clone verification. The product is meant to work alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line development workflows. ESI-Mine is a platform that can be used for high-throughput mass spectometry (MS) analysis. It enables the retrieval of living copies of hits that are normally destroyed during MS procedures.

People

Name
Role
Related Golden topics

Craig Cardella

Sales and Marketing Director, North America

Frank F. Craig

Director & CEO

John Mayfield

Finance Director

Marian Rehak

VP, Research and Development

Matthew Dunne

Global Distribution Manager

Rob Marchmont

VP, Sales and Marketing

Rob Treanor

Director of Operations

Infobox

Related Topics

Edits on 21 April, 2018
Melanie Manipula
Melanie Manipula edited on 21 April, 2018 9:07 am
Edits made to:
Topic thumbnail

Sphere Fluidics

Company commercializing single cell analysis systems

Melanie Manipula"Initial topic creation"
Melanie Manipula created this topic on 21 April, 2018 7:49 am
Edits made to:
Description
Academic papers
People
Further reading
Documentaries, videos and podcasts
Companies
Products
Topic thumbnail

 Sphere Fluidics

Company commercializing single cell analysis systems

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.